Keenova Therapeutics plc - Company Profile

Powered by

All the sales intelligence you need on Keenova Therapeutics plc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Keenova Therapeutics plc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Keenova Therapeutics plc.

Back to companies

Keenova Therapeutics plc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Keenova Therapeutics plc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Keenova Therapeutics plc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Marc Yoskowitz

Chairman Executive Board Since: 2024 Age: 51

Mr Marc Yoskowitz has been the Chairman of the company since 2024. Prior to this, he served as the Director at Mereo BioPharma. Previously, he served as the Director at Endo, Inc.

Read Hide full bio of Marc Yoskowitz

Sigurdur Olafsson

President; Director; Chief Executive Officer Executive Board Since: 2022 Age: 57

Mr. Sigurdur Olafsson has been President, Chief Executive Officer, and Director of the company since 2022. Prior to this, he served as the Chief Executive Officer of Hikma Pharmaceuticals. Previously, he served as the President and Chief Executive Officer of the Global Generic Medicines Group of Teva Pharmaceuticals. Mr. Olafsson also served as the President of Actavis plc (Watson) and CEO of the Actavis Group.

Read Hide full bio of Sigurdur Olafsson

Christiana Stamoulis

President; Chief Financial Officer Senior Management Since: 2025

Mr Christiana Stamoulis has been the President and Chief Financial Officer of the company since 2025. Prior to this, she served as the Executive Vice President and Chief Financial Officer at Incyte Corp. Previously, she served as the President and Chief Financial Officer at Unum Therapeutics and Senior Vice President of Corporate Strategy and Business Development at Vertex Pharmaceuticals.

Read Hide full bio of Christiana Stamoulis

Cheryl Stouch s

Executive Vice President; Chief Information Officer Senior Management

Ms Cheryl Stouch has been the Executive Vice President and Chief Information Officer of the company since 2025. Prior to this, she served as the Senior Vice President, Information Technology and Chief Information Officer at Endo, Inc. Previously, she served as the Executive Director of IT Corporate Functions & End User Services at Endo.

Read Hide full bio of Cheryl Stouch s

Mark Tyndall

Executive Vice President; Corporate Secretary; Chief Legal Officer Senior Management Since: 2022 Age: 48

Mr. Mark Tyndall has been the Corporate Secretary, Executive Vice President and Chief Legal Officer of the company since 2022. Prior to this, he served as the Senior Vice President and U.S. General Counsel at Keenova.

Read Hide full bio of Mark Tyndall
Gain a 360-degree view of Keenova Therapeutics plc and make more informed decisions for your business Gain a 360-degree view of Keenova Therapeutics plc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer